Bovine adenovirus
A cattle virus causing respiratory and gastrointestinal disease worldwide.
Last updated
Bovine adenovirus (BAdV) belongs to the Adenoviridae family and infects cattle. Ten serotypes have been identified, and the virus occurs worldwide, with higher prevalence in Africa and Central America. It typically causes illness in the digestive or respiratory systems, but depending on the serotype, it can also lead to eye problems, generalised symptoms, or contribute to enzootic pneumonia. Not all infections lead to disease, since the virus can be found in healthy animals.
Infected cattle shed the virus in respiratory secretions or faeces for about ten days, though some animals become persistently infected and excrete it for much longer.
Clinical signs are more common in younger cattle as maternal antibodies fade, sometimes starting as early as two weeks old. Digestive signs include diarrhoea, reduced appetite, and a swollen belly. Respiratory signs include coughing, clear nasal discharge, laboured breathing, and rapid breathing.
These signs can worsen if a secondary infection occurs. Generalised disease may bring fever, weight loss, depression, weakness, swollen lymph nodes, and lethargy. Sudden death has also been reported.
A definitive diagnosis requires a fourfold rise in antibody titre over the course of the illness. Finding the virus alone is not enough to confirm diagnosis because it can be present in healthy cattle. Virus isolation is the only way to identify the serotype. Postmortem exams may show lesions in the digestive or respiratory tract and enlarged lymph nodes.
Treatment is supportive when possible. Antibiotics may be given to prevent secondary infections. Control measures include ensuring calves get enough colostrum at birth, separating different age groups, and providing good ventilation and clean bedding. Vaccination of young cattle can reduce the severity and frequency of disease, but multiple doses are needed, often combined with other agents, and the vaccine is not available everywhere.
Quick Facts
- Serotypes
- 10
Facts from the source article.
Taxonomy & Global Reach
Bovine adenovirus, commonly abbreviated as BAdV, is a pathogen belonging to the Adenoviridae family that specifically targets cattle. To date, ten distinct serotypes have been formally recognised, each capable of producing a somewhat different clinical picture in affected herds. The virus enjoys a truly worldwide distribution, meaning no continent is entirely free of its presence. Nevertheless, certain regions bear a disproportionate burden of infection.
Africa and Central America stand out as areas where BAdV is particularly prevalent, likely reflecting the density of cattle populations and local husbandry practices in those parts of the world. The existence of multiple serotypes adds a layer of complexity to both surveillance and control efforts, since a single serotype may be responsible for gastrointestinal disease while another contributes to respiratory illness or even enzootic pneumonia. This serotype-dependent variation means that veterinarians working in different regions may encounter very different presentations of what is, fundamentally, the same viral family member. Understanding which serotypes circulate locally remains a critical step in any regional disease-management strategy.
Clinical Spectrum & Diagnostic Hurdles
The clinical picture of BAdV infection is remarkably broad, shifting depending on which serotype is involved. In its most common form, the virus attacks either the gastrointestinal tract or the respiratory system, though ocular involvement and generalised systemic illness are also documented. Younger animals are disproportionately affected, with cases emerging as early as two weeks of age once maternal antibody protection begins to fade. Gastrointestinal presentations include diarrhoea, loss of appetite, and a visibly distended abdomen.
Respiratory disease manifests through persistent coughing, clear nasal discharge, laboured breathing, and an elevated respiratory rate. When a secondary bacterial infection takes hold, the clinical picture deteriorates markedly. In severe generalised cases, affected cattle may show fever, progressive weight loss, marked depression, weakness, swollen lymph nodes, and profound lethargy, and even sudden death has been reported. Diagnosing BAdV is notoriously difficult because the virus can be recovered from perfectly healthy cattle, meaning its mere presence does not confirm active disease.
A definitive diagnosis requires demonstrating a fourfold rise in antibody titre over the course of the illness. Identifying the specific serotype demands virus isolation in the laboratory, and postmortem examination of fallen animals may reveal characteristic lesions in the gut or lungs alongside enlarged lymph nodes.
Treatment Approaches & Herd Management
Because no specific antiviral therapy exists for BAdV, clinical management focuses on supporting the animal through the illness. Symptomatic treatment is the cornerstone of care, and where secondary bacterial infections are suspected or confirmed, a course of antibiotics is typically administered to prevent the condition from worsening. Prevention, however, offers far more promise than cure. Ensuring that newborn calves receive an adequate volume of quality colostrum is one of the most effective single measures, as it provides the passive immunity that shields young stock during the vulnerable window when maternal antibodies are waning.
Beyond colostrum management, practical husbandry adjustments play a significant role in reducing transmission. Separating calves from older cattle, maintaining good airflow and ventilation in housing, and providing clean, dry bedding all help lower the incidence of disease within a herd. Vaccination of young cattle represents another important tool, capable of reducing both the frequency and the severity of outbreaks. In practice, the vaccine requires multiple doses to build adequate protection and is typically administered in combination with agents targeting other common bovine pathogens.
A notable limitation is that the vaccine is not available in every country, leaving some regions without this critical preventive option.
Shedding, Persistence & the Silent Carrier Problem
One of the most challenging aspects of BAdV from a control perspective is the way the virus moves through a herd. After initial infection, cattle typically shed the virus in their respiratory secretions or faeces for a period of roughly ten days, during which they can transmit the pathogen to susceptible animals. However, a subset of infected cattle becomes persistently infected, meaning they continue to excrete the virus well beyond that initial ten-day window, acting as long-term reservoirs within the population.
This persistent shedding complicates eradication efforts, as the virus can linger in a herd long after the acute clinical phase has passed. The situation is further complicated by the fact that BAdV can be isolated from cattle that show absolutely no signs of illness. These asymptomatic carriers are invisible to routine observation yet still capable of spreading the virus to vulnerable young animals. This dual reality—healthy-looking cattle harbouring the pathogen alongside persistently infected individuals—makes it extremely difficult to identify and remove sources of infection from a herd.
It also explains why simple detection of the virus in a sample is insufficient for diagnosis and why serological confirmation through paired antibody testing remains essential for proving active disease rather than mere exposure.
More in Bovine diseases
Sources
Compiled from Wikipedia and the sources listed below. Text from Wikipedia is available under CC BY-SA 4.0; this entry is adapted from it.
- Wikipedia: Bovine adenovirus (CC BY-SA 4.0).
- Word definitions: the Codexery glossary, each quoted from its Wikipedia article.
Spotted an error? Know more?
Reader corrections go straight into our review queue. Suggest an edit · How this site is sourced
